P814: ANALYSIS OF TP53 ALTERATIONS BY WGS REVEALS BIALLELIC 17P DELETIONS IN MULTIPLE MYELOMA

P814: ANALYSIS OF TP53 ALTERATIONS BY WGS REVEALS BIALLELIC 17P DELETIONS IN MULTIPLE MYELOMA

Bibliographic Details
Main Authors:	Marietta Truger, Stephan Hutter, Wencke Walter, Xiang Zhou, Christine Riedhammer, Manja Meggendorfer, Heiko Müller, Wolfgang Kern, Torsten Haferlach, Hermann Einsele, K Martin Kortum, Claudia Haferlach, Leo Rasche
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000970160.66665.6b

Similar Items

P690: IDENTIFICATION OF CLINICALLY RELEVANT VARIANT-LEVEL SEX-BIAS IN SF3B1 K700/K666 AND IDH2 R140/R172
by: Maki Sakuma, et al.
Published: (2023-08-01)

S161: UBA1 NON-M41 VARIANTS ARE MORE AGGRESSIVE THAN UBA1 M41 VARIANTS IN THEIR HEMATOLOGICAL MANIFESTATIONS.
by: Maki Sakuma, et al.
Published: (2023-08-01)

Clinical application of whole transcriptome sequencing for the classification of patients with acute lymphoblastic leukemia
by: Wencke Walter, et al.
Published: (2021-08-01)

P689: CLASSIFICATION OF MDS AND AML BASED SOLELY ON GENETICS OMITTING BLAST COUNTING – A WAY TO RESOLVE THE DISCREPANCIES BETWEEN CLASSIFICATIONS ACCORDING TO WHO AND ICC?
by: Claudia Haferlach, et al.
Published: (2023-08-01)

P694: RISK ASSESSMENT ACCORDING TO IPSS-M IS SUPERIOR TO AML ELN 2022 RISK CLASSIFICATION IN MDS/AML PATIENTS DEFINED BY ICC – IS AN INCLUSION INTO AML TRIALS JUSTIFIED?
by: Sandra Huber, et al.
Published: (2023-08-01)

P735: THE ROLE OF SF3B1 MUTATIONS IN MYELODYSPLASTIC SYNDROMES
by: S. Huber, et al.
Published: (2022-06-01)

P708: HIGH MUTATIONAL CONCORDANCE IN PAIRED BONE MARROW AND PERIPHERAL BLOOD SAMPLES IN PATIENTS WITH CONFIRMED OR SUSPECTED MYELODYSPLASTIC NEOPLASM
by: Natalie Wossidlo, et al.
Published: (2023-08-01)

P411: SF3B1 MUTATIONS IN AML ARE STRONGLY ASSOCIATED WITH MECOM REARRANGEMENTS AND MAY BE INDICATIVE OF AN MDS PRE-PHASE
by: S. Huber, et al.
Published: (2022-06-01)

Molecular characterization of AML with RUNX1-RUNX1T1 at diagnosis and relapse reveals net loss of co-mutations
by: Alexander Höllein, et al.
Published: (2019-02-01)

Dark-matter matters: Discriminating subtle blood cancers using the darkest DNA.
by: Laxmi Parida, et al.
Published: (2019-08-01)

P1213: ARTIFICIAL INTELLIGENCE TO PREDICT MEDICAL DIAGNOSIS FROM FLOW CYTOMETRIC RAW DATA IN MATURE B-CELL AND T-CELL NEOPLASMS, AML, ALL, MDS AND MULTIPLE MYELOMA
by: Martha-Lena Müller, et al.
Published: (2023-08-01)

P533: A FULLY AUTOMATED SUPERVISED AI-BASED CELL CLASSIFIER TO ACCURATELY FLAG PATHOLOGICAL SIGNATURE CELLS IN 28,285 REAL-WORLD BLOOD SMEARS
by: Christopher Maier, et al.
Published: (2023-08-01)

P890: COMBINING SKY92 GENE EXPRESSION PROFILING WITH CYTOGENETICS ACCORDING TO R2-ISS FOR MULTIPLE MYELOMA RISK CLASSIFICATION: THE FIRST PROSPECTIVE EVIDENCE
by: Xiang Zhou, et al.
Published: (2023-08-01)

Pathophysiologic and clinical implications of molecular profiles resultant from deletion 5q
by: Vera Adema, et al.
Published: (2022-06-01)

P707: MUTATIONS IN THE COHESIN GENE STAG2 ARE ASSOCIATED WITH REDUCED INFLAMMATORY GENEEXPRESSION AND AN INCREASE IN HEMATOPOIETIC STEM CELL POPULATIONS IN MYELODYSPLASTICSYNDROME PATIENTS
by: Shubhra Ashish Bhattacharya, et al.
Published: (2023-08-01)

P52 RISK STRATIFICATION COMBINING SKY92 GENE EXPRESSION PROFILING AND TRADITIONAL FISH IN MULTIPLE MYELOMA: THE FIRST PROSPECTIVE EVIDENCE IN THE R2-ISS ERA
by: X. Zhou, et al.
Published: (2023-05-01)

Methods to detect minimal residual disease
by: Torsten Haferlach
Published: (2018-06-01)

Advancing leukemia diagnostics: Role of Next Generation Sequencing (NGS) in acute myeloid leukemia
by: Torsten Haferlach
Published: (2020-09-01)

Maturation State-Specific Alternative Splicing in <i>FLT3</i>-ITD and NPM1 Mutated AML
by: Anna Wojtuszkiewicz, et al.
Published: (2021-08-01)

Novel scheme for defining the clinical implications of TP53 mutations in myeloid neoplasia
by: Waled Bahaj, et al.
Published: (2023-08-01)

Pathophysiologic and clinical implications of molecular profiles resultant from deletion 5q
by: Adema, V, et al.
Published: (2022)

P814: Cases of survivorship: Prenatal counseling for double heterozygosity in skeletal dysplasia
by: Andrea Schelhaas, et al.
Published: (2024-01-01)

P8.14 ELASTIC MODULUS OF HUMAN AORTAS AS A MEASURE OF STIFFNESS
by: Kathleen Connolly*, et al.
Published: (2015-11-01)

The Link between Cytogenetics/Genomics and Imaging Patterns of Relapse and Progression in Patients with Relapsed/Refractory Multiple Myeloma: A Pilot Study Utilizing 18F-FDG PET/CT
by: Xiang Zhou, et al.
Published: (2020-08-01)

Acute myeloid leukemia
by: Torsten Haferlach, (Coordinating Author)
Published: (2019-06-01)

P814: CLINICAL CHARACTERISTICS AND GENE MUTATION ANALYSIS OF 148 CHILDREN WITH FANCONI ANEMIA IN CHINA
by: L. Chang, et al.
Published: (2022-06-01)

P846: EXPRESSION SIGNATURE OF TP53 BIALLELIC INACTIVATION IDENTIFIES A GROUP OF MULTIPLE MYELOMA PATIENTS WITHOUT THIS GENETIC CONDITION BUT WITH DISMAL OUTCOME.
by: C. De Ramón, et al.
Published: (2022-06-01)

Biallelic TET2 mutations confer sensitivity to 5′-azacitidine in acute myeloid leukemia
by: Friedrich Stölzel, et al.
Published: (2023-01-01)

UPM Ambil 4,814 Pelajar Baharu
by: Universiti Putra Malaysia, Bahagian Komunikasi Korporat
Published: (2009)

Micropropagation of the new apple rootstock ‘G. 814’
by: Aline Meneguzzi, et al.

Myeloid malignancies with 5q and 7q deletions are associated with extreme genomic complexity, biallelic TP53 variants, and very poor prognosis
by: Beth A. Pitel, et al.
Published: (2021-02-01)

Frequency and prognostic impact of CEBPA proximal, distal and core promoter methylation in normal karyotype AML: a study on 623 cases.
by: Annette Fasan, et al.
Published: (2013-01-01)

Identifying novel mechanisms of biallelic TP53 loss refines poor outcome for patients with multiple myeloma
by: Enze Liu, et al.
Published: (2023-09-01)

The Nuclear Proteins TP73 and CUL4A Confer Resistance to Cytarabine by Induction of Translesion DNA Synthesis via Mono-ubiquitination of PCNA
by: Miriam Rehberger, et al.
Published: (2022-05-01)

P331: WGS/WES as unique diagnostic tool for the genetic screening of patients with craniosynostosis
by: Alexandra Topa, et al.
Published: (2023-01-01)

THREE CASES OF TP53 BIALLELIC-MUTATED AML/MDS BRIDGED TO ALLO-HSCT BY AZA/VEN THERAPY
by: T. Ueda, et al.
Published: (2024-01-01)

Generation of iPSC line from urine cells of hemophilia A with F8 (p. R814X) mutation
by: Wenwen Sun, et al.
Published: (2022-04-01)

GT-WGS: an efficient and economic tool for large-scale WGS analyses based on the AWS cloud service
by: Yiqi Wang, et al.
Published: (2018-01-01)

P573: Biallelic missense NEXN variants lead to recessive severe neonatal cardiomyopathy
by: Casey Thornton, et al.
Published: (2023-01-01)

P678: Biallelic variants in BECN1 are associated with a complex neurodevelopmental syndrome
by: Farid Ullah, et al.
Published: (2024-01-01)